Current reading list (March 2021)
We have been keeping an eye on the methods literature, and think people with an interest in the Bias Methods Group may be interested in the following aticles published recently:
Alexander PE, Debono VB, Mammen MJ, et al. COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine. J Clin Epidemiol 2020;123:120-126.
Bero LA. Improving the Quality of Systematic Reviews in Public Health: Introduction to the Series. Am J Public Health 2020;110:1601-2.
Bero LA. Producing Independent, Systematic Review Evidence: Cochrane's Response to COVID-19. Am J Public Health 2020;110:952-3.
Bertizzolo L, Bossuyt PM, Atal I, Ravaud P, Dechartres A. External factors may influence Cochrane reviewers when classifying the risk of bias of original reports. J Clin Epidemiol 2020;123:1-8.
Boutron I, Chaimani A, Meerpohl JJ, et al. The COVID-NMA Project: Building an Evidence Ecosystem for the COVID-19 Pandemic. Ann Intern Med 2020;173:1015-7.
Kahan BC, Ahmad T, Forbes G, Cro S. Public availability and adherence to prespecified statistical analysis approaches was low in published randomized trials. J Clin Epidemiol 2020;128:29-34.
Lindsley K, Fusco N, Teeuw H, Mooij E, Scholten R, Hooft L. Poor compliance of clinical trial registration among trials included in systematic reviews: a cohort study. J Clin Epidemiol 2020;132:79-87.
Luijendijk HJ, Page MJ, Burger H, Koolman X. Assessing risk of bias: a proposal for a unified framework for observational studies and randomized trials. BMC Med Res Methodol 2020;20:237.
Lundh A, Boutron I, Stewart L, Hróbjartsson A. What to do with a clinical trial with conflicts of interest. BMJ Evid Based Med 2020;25:157-8.
Nejstgaard CH, Bero L, Hróbjartsson A, et al. Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations. Cochrane Database Syst Rev 2020;12:Mr000040.
Østengaard L, Lundh A, Tjørnhøj-Thomsen T, et al. Influence and management of conflicts of interest in randomised clinical trials: qualitative interview study. BMJ 2020;371:m3764.
Oikonomidi T, Boutron I, Pierre O, Cabanac G, Ravaud P. Changes in evidence for studies assessing interventions for COVID-19 reported in preprints: meta-research study. BMC Med 2020;18:402.
Page MJ, Sterne JAC, Higgins JPT, Egger M. Investigating and dealing with publication bias and other reporting biases in meta-analyses of health research: A review. Res Synth Methods 2020; doi: 10.1002/jrsm.1468
Puljak L, Ramic I, Arriola Naharro C, et al. Cochrane risk of bias tool was used inadequately in the majority of non-Cochrane systematic reviews. J Clin Epidemiol 2020;123:114-9.
Stoll M, Mancini A, Hubenschmid L, et al. Discrepancies from registered protocols and spin occurred frequently in randomized psychotherapy trials-A meta-epidemiologic study. J Clin Epidemiol 2020;128:49-56.
Turner RM, Rhodes KM, Jones HE et al. Agreement was moderate between data-based and opinion-based predictions of biases affecting randomized trials within meta-analyses. J Clin Epidemiol 2020;125:16-25.
Former reading lists
The July 2021 reading list can be found here.
The December 2019 reading list can be found here.
The March 2019 reading list can be found here.
The August 2018 reading list can be found here.
The February 2018 reading list can be found here.